Drug name - Tosymra
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8268791 | UPSHER SMITH LABS | Alkylglycoside compositions for drug administration |
May, 2026
(3 years from now) | |
| US8440631 | UPSHER SMITH LABS | Compositions for drug administration |
May, 2026
(3 years from now) | |
| US9283280 | UPSHER SMITH LABS | Compositions for drug administration |
May, 2026
(3 years from now) | |
| US10603305 | UPSHER SMITH LABS | Formulations comprising triptan compounds |
Jun, 2030
(7 years from now) | |
| US9974770 | UPSHER SMITH LABS | Formulations comprising triptan compounds |
Jun, 2030
(7 years from now) | |
| US9610280 | UPSHER SMITH LABS | Formulations comprising triptan compounds |
Jun, 2030
(7 years from now) | |
| US9211282 | UPSHER SMITH LABS | Formulations comprising triptan compounds |
Jul, 2031
(8 years from now) | |
Drugs and Companies using SUMATRIPTAN ingredient
Treatment: Acute treatment of migraine
Dosage: SPRAY;NASAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 10MG/SPRAY | SPRAY;NASAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.